SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

FDA approves first at-home starting dose for subcutaneous Leqembi

The U.S. Food and Drug...

BIIBESAIY

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.